Suchergebnisse - "Liu, Tingting"

PubPharm (32)

1

Site-specific controlled-release nanoparticles for immune reprogramming via dual metabolic inhibition against triple-negative breast cancer

enthalten in: Journal of controlled release : official journal of the Controlled Release Society | 2024

von She, W. | Li, H. | Wang, Z. | +5

2

Discovery of Tetrahydropyrazolopyrazine Derivatives as Potent and Selective MYT1 Inhibitors for the Treatment of Cancer

enthalten in: Journal of medicinal chemistry | 2024

von Wang, Y. | Wang, C. | Liu, T. | +8

3

Multi-therapies Based on PARP Inhibition : Potential Therapeutic Approaches for Cancer Treatment

enthalten in: Journal of medicinal chemistry | 2022

von Zhang, J. | Gao, Y. | Zhang, Z. | +5

4

Oncolytic Vaccinia Virus Harboring Aphrocallistes vastus Lectin Inhibits the Growth of Cervical Cancer Cells Hela S3

enthalten in: Marine drugs | 2021

von Ni, J. | Feng, H. | Xu, X. | +4

5

Pharmacologic Targeting of Mcl-1 Induces Mitochondrial Dysfunction and Apoptosis in B-Cell Lymphoma Cells in a TP53- and BAX-Dependent Manner

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Liu, T. | Lam, V. | Thieme, E. | +9

6

Exceptional response to the ALK and ROS1 inhibitor lorlatinib and subsequent mechanism of resistance in relapsed ALK F1174L-mutated neuroblastoma

enthalten in: Cold Spring Harbor molecular case studies | 2021

von Liu, T. | Merguerian, M. | Rowe, S. | +3

7

Oncolytic Vaccinia Virus Expressing White-Spotted Charr Lectin Regulates Antiviral Response in Tumor Cells and Inhibits Tumor Growth In Vitro and In Vivo

enthalten in: Marine drugs | 2021

von Wang, X. | Zhou, N. | Liu, T. | +4

8

Duvelisib (Copiktra) in relapsed or refractory chronic lymphocytic leukemia : safety and efficacy

enthalten in: Expert review of anticancer therapy | 2021

von Nikolaenko, L. | Liu, T. | Danilov, A.

9

Recent progress in agents targeting polo-like kinases : Promising therapeutic strategies

enthalten in: European journal of medicinal chemistry | 2021

von Zhang, Z. | Xing, X. | Guan, P. | +4

10

Dual-target Inhibitors Based on BRD4 : Novel Therapeutic Approaches for Cancer

enthalten in: Current medicinal chemistry | 2021

von Zhang, S. | Chen, Y. | Tian, C. | +4